Summary
Radiographic procedures which require the intravascular administration of water-soluble radiocontrast media are performed with increasing frequency. Each examination carries risks that are related either to the technique itself or to the opaque medium chosen. The pathogenesis of radiocontrast media-related adverse effects cannot be explained by a unique theory. The major factors implicated are direct chemotoxic effects and the physicochemical properties of contrast media, the latter being the basis for development of new contrast agents. With non-ionic opaque media cardiovascular adverse effects, heat sensation and local pain are observed less frequently. However, it remains unclear whether the incidence of organ dysfunction or anaphylactic reactions with nonionic contrast media currently used can be reduced. This review compares ionic and nonionic contrast media, and current thoughts on the pathophysiology and treatment of adverse reactions are presented.
Similar content being viewed by others
References
Adams MD, Hopkins RM, Ferrendelli JA. A rat model for evaluating contrast media toxicity. Investigative Radiology 23: S217, 1988
Almén T. Contrast agent design: some aspects on the synthesis of water soluble contrast agents of low osmolarity. Journal of Theoretical Biology 24: 216, 1969
Andrew E, Shaw D, Sveen K, Holager T, Dahlstrom K. Adverse reactions with iohexol in the vascular field: experiences from clinical trials. Investigative Radiology 19: S143, 1984
Ansell, G, Tweedie McK, West CR. The current status of reactions to intravenous contrast media. Investigative Radiology 15: S32, 1980
Aulie A. Effect of iohexol, metrizamide and ioxoglate on the blood-brain barrier. Acta Radiologica 362: SI3, 1980
Bettmann MA, Geller SC, McClennan B, et al. Current use of low-osmolality contrast agents —results of a survey. American Journal of Roentgenography 153: 1079–1084, 1989
Byrd L, Sherman RL. Radiocontrast media-induced acute renal failure: a clinical and pathophysiological review. Medicine 58: 270, 1979
Caillé JM, Allard M. Neurotoxicity of hydrosoluble iodine contrast media. Investigative Radiology 23: S210, 1988
Carr DH, Walker AC. Contrast media reactions: experimental evidence against the allergy theory. British Journal of Radiology 57: 469, 1984
Cohan RH, Dunnick NR, Bashore M. Treatment of reactions to radiographic contrast material. American Journal of Roentgenography 151: 263, 1988
D’Elia JA, Gleason RD, Alday M. Nephrotoxicity from angiographic contrast material: a prospective study. American Journal of Medicine 72: 719, 1982
Dukes MNG, Ansell G. Radiological contrast media and radiopharmaceuticals. In Dukes (Ed.) Meyler’s side effects of drugs, 9th ed., p. 749, Excerpta Medica, Amsterdam, 1980
Endrich B, Ring J, Intaglietta M. Effects of radiopaque contrast media on the microcirculation of the rabbit omentum. Radiology 132: 331, 1979
Frink RJ, Merrick B, Lowe HM. Mechanism of the bradycardias during angiocardiography. American Journal of Cardiology 35: 17, 1975
Grebe SF, Müller H. Hyperthyreose-Risiko bei Kontrastmittel-verabreichung. In Digitale Radiographie, p. 339, Schnetztor-Verlag, Konstanz, 1984
Grehn S, Steidle B, Seif FJ. Changes in thyroid function following administration of iodinated contrast material in patients from an endemic goiter belt. Radiology 143: 825, 1982
Hambey RI, Aintablian A, Wisoff BG. Effects of contrast medium on left ventricular pressure and volume with emphasis on coronary artery disease. American Heart Journal 93: 9, 1977
Hanley PC, Holmes DR, Julsrud PR, Smith HC. Use of conventional and newer radiographie contrast agents in coronary angiography. Progress in Cardiovascular Diseases 6: 435, 1986
Hartmann HG. Nephrotoxizität von ionischen und nicht ionischen Kontrastmitteln -qualitative Bestimmung der Enzymurie. In Zeitler (Ed.) Klinische Pharmakologie der kontrastmittel. Symposion Nürnberg 1985, p.123, Schnetztor Verlag, Konstanz, 1985
Harvey LA, Caldicott WJH. The influence of contrast medium dose on filtration in the rabbit kidney. Investigative Radiology 18: 441, 1983
Hellige G, Baller D, Hoeft A, Wolpers HG, Zipfel J. The importance of electrolyte shifts and calcium binding on cardiotoxicity of contrast media. In Amiel & Moreau (Eds) Contrast media in radiology: appraisal and prospects, p. 80, Springer-Verlag, Berlin, 1982
Higgins CB, Schmidt W. Direct and reflex myocardial effects of intracoronary administered contrast materials in the anesthetized and conscious dog: comparison of standard and newer contrast materials. Investigative Radiology 13: 205, 1978
Junck L, Marshall WH. Neurotoxicity of radiological contrast agents. Annals of Neurology 13: 469, 1983
Kahn JK, Rutherford BD, McConahay DR, et al. High-dose contrast agent administration during complex coronary angioplasty. American Heart Journal 120: 533–536, 1990
Katzberg RW. Renal effects of contrast media. Investigative Radiology 23: S157, 1988
Kinnison ML, Powe NR, Steinberg EP. Results of randomized controlled trials of low-versus high-osmolality contrast media. Radiology 170: 381, 1989
Klinke WP, Grace M, Miller R, et al. A multicenter randomized trial of ionic (ioxaglate) and nonionic (iopamidol) low-osmolality contrast agents in cardiac angiography. Clinical Cardiology 12: 689–696, 1989
Klow NE, Refsum H, Hevroy O, et al. Effect of intracoronary contrast medium on left ventricular diastolic pressure-volume relationships. American Heart Journal 119: 59–63, 1990
Lalli AF. Contrast media reactions: data analysis and hypothesis. Radiology 134: 1, 1980
Lasser EC. Prekallikrein-kallikrein conversion rate as a predictor of contrast material catastrophes. Radiology 140: 11, 1981
Lasser EC. A coherent biochemical basis for increased reactivity to contrast material in allergic patients: a novel concept. American Journal of Roentgenology 149: 1281, 1987
Lasser EC, Berry CC, Tulner LB, Santini LC, Lang EK, et al. Protective effects of corticosteroids in contrast material anaphylaxis. Investigative Radiology 23: S193, 1987
Lasser EC, Walters AJ, Lang JH. An experimental basis for histamine release in contrast material reactions. Radiology 125: 49, 1974
Leeds NE. The clinical application of radiopharmaceuticals. Drugs 40: 713–721, 1990
Levitan H, Rapaport SI. Contrast media: quantitative criteria for designing compounds with low toxicity. Acta Radiologica Diagnostica 17: 81, 1976
Malette LE, Gomez LS. Systemic hypocalcemia after clinic injections of radiographic contrast media: amelioration by omission of calcium chelating agents. Radiology 148: 677, 1983
Maley P, Olivecrona H, Almén T, Golman K. Interaction between chlorpromazine and intrathecally injected nonionic contrast media in non anaesthetized rabbits. Neuroradiology 26: 235, 1984
Mandai AK, Lightfoot BO, Treat RC. Mechanisms of protection in acute renal failure. Circulatory Shock 11: 245, 1983
Missri J. Ventricular fibrillation during coronary angiography: reduced incidence with noniomc contrast media. Catheterization and Cardiovascular Diagnosis 19: 4, 1990
Moreau JF. Nephrotoxicity of uroangiographic contrast media. In Amiel & Moreau (Eds) Contrast media in radiology: appraisal and prospects, pp.195, Springer-Verlag, Berlin, 1982
Moreau JF, Lesavre P, DeLuca H, Henessen U, Fischer AM, et al. General toxicity of water-soluble iodinated media. Investigative Radiology 23: S75, 1988
Morries TW, Ekholm SE, Simon JH, Marinetti GV, Harnish PP,et al. In vitro models for testing the metabolic effects of myelographic contrast media. Investigative Radiology 23: S213, 1988
Myers GE, Bloom FL. Cimetidine (Tagamet) combined with steroids and H1 antihistamines for the prevention of serious radiographic contrast material reactions. Catheterization and Cardiovascular Diagnosis 7: 65, 1981
Neoh SH. The in vitro activation of complement by radiologic contrast material and its inhibition with aminocaproic acid. Investigative Radiology 16: 152, 1981
Neumayer HH. Prevention of radiocontrast media induced nephrotoxicity by calcium channel blocker nitrendipine: a prospective randomised clinical trial. Nephrology Dialysis Transplantation 6: 1030, 1989
Nishimura RA, Holmes DR, McFarland TM. Ventricular arrythmias during coronary angiography in patients with angina pectoris or chest pain syndromes. American Journal of Cardiology 53: 1496, 1984
Peck WW, Slutsky RA, Mancini GBJ, Higgins CB. Combined actions of verapamil and contrast media on atrioventricular conduction. Investigative Radiology 19: 202, 1984
Perez-Gomez F, Garcia-Aguado A. Origin of ventricular reflexes caused by coronary angiography. British Heart Journal 39: 967, 1977
Ring J, Rothenberger KH. Anaphylaktoide Reaktionen nach Infusionen von Kontrastmitteln. Münchener Medizinische Wochenschrift 126: 657, 1984
Rothenberger K, Ring J. Das Wiederholungsrisiko von Kontrastmittelreaktionen bei der Urographie. Fortschritte der Medizin 33: 148, 1979
Sage MR. Kinetics of watersoluble contrast media in the central nervous system. American Journal of Neuroradiology 141: 815, 1983
Scherberich J, Tuengerthal S, Kollath J. Monitoring of contrast media toxicity by specific kidney tissue proteinuria of membrane antigens. In Taenzer & Zeitler (Eds) Contrast media in urography, angiography and computerized tomography, p. 37, Georg-Thieme-Verlag, Stuttgart, 1982
Schräder R, Schultz H, Wendt TH, Klepzig H, Kober G. Hämodynamische Nebenwirkungen eines ionischen und eines nichtionischen Kontrastmittels bei Patienten mit Vitien und pulmonaler Hypertonie. Zeitschrift für Kardiologie 75: 528, 1986
Schrott KM, Behrends B, Clauss W, Kaufmann J, Lehnen J. Iohexol in extretory urography: results of the drug monitoring program. Fortschritte der Medizin 104: 153, 1988
Shehadi WH. Contrast media adverse reactions: occurrence, recurrence and distribution patterns. Diagnostic Radiology 143: ll, 1982
Shehadi WH. Adverse reactions to intravascularly administered contrast media: A comprehensive study based on a prospective survey. American Journal of Roentgenology 124: 145, 1975
Siefert HM, Press WR, Speck U. Tolerance of iohexol after intracisternal, intracerebral and intraarterial injection in the rat. Acta Radiologica 362: S77, 1980
Slutsky R, Higgins C, Costello D. Mechanism of increase in left ventricular end-diastolic pressure after contrast ventriculography in patients with coronary artery disease. American Heart Journal 106: 107, 1983
Sovak M. Introduction to new contrast media. Investigative Radiology 19: S142, 1984
Speck U. Röntgenkontrastmittel. Ubersicht, Anwendung und pharmazeutische Aspekte, p. 7, Schering, Berlin, 1986
Steiner RM, Greinger RG, Memon N. The effect of contrast media of low osmolality on the peripheral arterial blood flow in dogs. Clinical Radiology 31: 621, 1980
Thompson WM, Mills SR, Bates M, Hedlund L, Rommel J. Pulmonary angiography with iopamidol ‘Renografin 76’ in normal and pulmonary hypertensive dogs. Acta Radiologica Diagnostica 24: 425, 1983
van Sonnenberg E, Neff CC, Pfister RC. Life-threatening hypotensive reactions to contrast administration: comparison of pharmacologie and fluid therapy. Radiology 162: 15, 1987
Walker AC, Carr DH. Reactions to radiographic contrast media: an attempt to detect specific anti-contrast antibodies in the sera of reactor patients. British Journal of Radiology 59: 531, 1986
Weikl A. Angiokardiographie mit nicht ionischen Kontrastmitteln beim Risikopatienten. In Felex et al. (Eds) Neues im Kontrastbild Herz und grosse Gefässe. Workshop Berlin 1986, p. 15, Schering, Berlin, 1987
Wink K, Hansel I, Amery A, et al. Contrast media in cardiology: comparison of hemodynamic cardiovascular reactions of an ionic high-osmolar and a nonionic low-osmolar contrast medium in cardioangiography. Herz/Kreislauf 22: 107–111, 1990
Wolf GL. The fibrillatory prospensities of contrast agents. Investigative Radiology 15: S208, 1980
Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic versus nonionic contrast agents in routine clinical praxis: comparison of adverse effects. American Journal of Roentgenology 152: 939, 1989
Wolf GL, Gerlings ED, Wilson WJ. Depression of myocardial contractility induced by hypertonic coronary injections in the isolated perfused dog heart. Radiology 107: 655, 1973
Wolf GL, Le Veen RF, Mulrey C. The influence of contrast media additives upon ventricular fibrillation threshold during coronary angiography in ischemic and normal canine hearts. Cardiovascular and Interventional Radiology 4: 145, 1981
Wolpers HG, Bailer D, Hoeft A, Korb H, Schräder R, et al. The effect of ion composition on cellular membrane potentials during selective coronary artériographie. Investigative Radiology 19: 291, 1984
Zelis R, Caudill CC, Baggette K, Mason DT. Reflex vasodilation by coronary angiography in human subjects. Circulation 52: 490, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Westhoff-Bleck, M., Bleck, J.S. & Jost, S. The Adverse Effects of Angiographic Radiocontrast Media. Drug-Safety 6, 28–36 (1991). https://doi.org/10.2165/00002018-199106010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199106010-00003